243 related articles for article (PubMed ID: 11086886)
1. Synthesis of new cardioselective M2 muscarinic receptor antagonists.
Mandelli GR; Maiorana S; Terni P; Lamperti G; Colibretti ML; Imbimbo BP
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1611-22. PubMed ID: 11086886
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of phenylacetyl derivatives having low central nervous system permeability as potent and selective M2 muscarinic receptor antagonists.
Watanabe T; Kakefuda A; Tanaka A; Takizawa K; Hirano S; Shibata H; Yamagiwa Y; Yanagisawa I
Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):53-68. PubMed ID: 9468637
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
[TBL] [Abstract][Full Text] [Related]
4. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
Hirose H; Aoki I; Kimura T; Fujikawa T; Numazawa T; Sasaki K; Sato A; Hasegawa T; Nishikibe M; Mitsuya M; Ohtake N; Mase T; Noguchi K
J Pharmacol Exp Ther; 2001 May; 297(2):790-7. PubMed ID: 11303071
[TBL] [Abstract][Full Text] [Related]
6. Tolterodine--a new bladder-selective antimuscarinic agent.
Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B
Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel succinamide derivatives having the 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one skeleton as potent and selective M2 muscarinic receptor antagonists. I.
Watanabe T; Kinoyama I; Kakefuda A; Okazaki T; Takizawa K; Hirano S; Shibata H; Yanagisawa I
Chem Pharm Bull (Tokyo); 1997 Jun; 45(6):996-1007. PubMed ID: 9214706
[TBL] [Abstract][Full Text] [Related]
8. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
Ehlert FJ; Oliff HS; Griffin MT
J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
[TBL] [Abstract][Full Text] [Related]
9. Activation of cerebral function by CS-932, a functionally selective M1 partial agonist: neurochemical characterization and pharmacological studies.
Iwata N; Kozuka M; Hara T; Kanek T; Tonohiro T; Sugimoto M; Niitsu Y; Kondo Y; Yamamoto T; Sakai J; Nagano M
Jpn J Pharmacol; 2000 Nov; 84(3):266-80. PubMed ID: 11138727
[TBL] [Abstract][Full Text] [Related]
10. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
Pei XF; Gupta TH; Badio B; Padgett WL; Daly JW
J Med Chem; 1998 Jun; 41(12):2047-55. PubMed ID: 9622546
[TBL] [Abstract][Full Text] [Related]
11. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P
J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
[TBL] [Abstract][Full Text] [Related]
12. Selective muscarinic antagonists. II. Synthesis and antimuscarinic properties of biphenylylcarbamate derivatives.
Naito R; Takeuchi M; Morihira K; Hayakawa M; Ikeda K; Shibanuma T; Isomura Y
Chem Pharm Bull (Tokyo); 1998 Aug; 46(8):1286-94. PubMed ID: 9734316
[TBL] [Abstract][Full Text] [Related]
13. J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors.
Mitsuya M; Mase T; Tsuchiya Y; Kawakami K; Hattori H; Kobayashi K; Ogino Y; Fujikawa T; Satoh A; Kimura T; Noguchi K; Ohtake N; Tomimoto K
Bioorg Med Chem; 1999 Nov; 7(11):2555-67. PubMed ID: 10632066
[TBL] [Abstract][Full Text] [Related]
14. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
[TBL] [Abstract][Full Text] [Related]
15. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
[TBL] [Abstract][Full Text] [Related]
16. Characterization of BIBN 99: a lipophilic and selective muscarinic M2 receptor antagonist.
Doods H; Entzeroth M; Ziegler H; Schiavi G; Engel W; Mihm G; Rudolf K; Eberlein W
Eur J Pharmacol; 1993 Sep; 242(1):23-30. PubMed ID: 8223934
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
Gillberg PG; Sundquist S; Nilvebrant L
Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109
[TBL] [Abstract][Full Text] [Related]
18. Discovery & development of selective M3 antagonists for clinical use.
Alabaster VA
Life Sci; 1997; 60(13-14):1053-60. PubMed ID: 9121347
[TBL] [Abstract][Full Text] [Related]
19. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
[TBL] [Abstract][Full Text] [Related]
20. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors.
Purkerson SL; Potter LT
J Pharmacol Exp Ther; 1998 Feb; 284(2):707-13. PubMed ID: 9454818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
